Ladisch Douglass Insulin Bill Signed into Law, Capping 30-day Supply at $35 for State-Regulated Plans

ELMHURST, Ill. – Supporting efforts to make insulin more affordable, a proposal carried by state Rep. Jenn Ladisch Douglass, D-Elmhurst, to cap the 30-day supply of insulin for state-regulated plans at $35 was signed into law Friday.

“Insulin is not something that is optional for anyone,” Ladisch Douglass said. “It’s a critical component of care and an ongoing treatment for those dealing with diabetes. As someone who has lived with type 1 diabetes for 30 years, I’m thankful for the advocacy and bipartisan support we received on this plan which will help save lives.”

Ladisch Douglass’ House Bill 2189 will lower the existing co-pay cap – for state-regulated plans – on a 30-day supply of covered prescription insulin drugs from $100 to $35. The measure also establishes a discount program for eligible residents to purchase insulin at a discounted post-rebate price and pursue reimbursement from their health insurer.

According to the Illinois Department of Public Health, approximately 1.3 million adults in Illinois have diabetes. Another 3.6 million state residents are believed to have prediabetes.

“Implementation of this law is going to help a lot of people in every part of the state, and it’s critical that we build on it,” Ladisch Douglass said. “More work remains, and I look forward to engaging stakeholders on ways we can continue to expand health care access and lower costs for families.”

House Bill 2189 passed with bipartisan support without opposition. Gov. J.B. Pritzker signed the proposal on Friday.

For more information, please contact Office.RepJLD@gmail.com.